glp-1 and type 1 diabetes Is the Same as Ozempic? Understanding Key Differences The role of GLP1 receptor

A total of 225 participants were included in the modified intention-to-treat population and assigned to tirzepatide 10 mg ( n = 73), 15 mg ( n = 77), or placebo ( n = 75), alongside lifestyle modifications

This Medication Guide section is provided for general educational purposes only

In the SURMOUNT 1 trial, tirzepatide at doses of 5 mg, 10 mg and 15 mg were evaluated against placebo, with pooled tirzepatide groups resulting in significant decreases in total cholesterol, LDL-C, VLDL-C, FFA, and triglycerides and an increase in HDL-C at week 72 of follow-up [35]

Others report more dramatic results, particularly patients using tirzepatide or those starting at higher body weights

Mezquita Raya, M